Cardiff Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cardiff Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Cardiff Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.3M, a 29.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.3M -$539K -29.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.44M -$539K -27.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.57M -$541K -25.6% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.71M -$543K -24.1% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.84M -$545K -22.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.98M -$546K -21.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $2.12M -$545K -20.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.25M -$545K -19.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.39M -$629K -20.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $2.52M +$2.35M +1318% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.66M +$2.4M +919% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.8M +$2.45M +715% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.02M +$2.59M +613% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $178K -$324K -64.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $261K -$357K -57.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $343K -$354K -50.8% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $423K -$1.08M -71.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $502K -$1.16M -69.8% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $618K -$1.2M -66% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $697K +$697K Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.5M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.66M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.82M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.